Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Hepatitis B virus (HBV) genotype determination by the COBAS AmpliPrep/COBAS TaqMan HBV Test, v2.0 in serum and plasma matrices.

Goedel S, Rullkoetter M, Weisshaar S, Mietag C, Leying H, Boehl F.

J Clin Virol. 2009 Jul;45(3):232-6. doi: 10.1016/j.jcv.2009.05.021. Epub 2009 Jun 16.

PMID:
19535286
2.

Fully automated quantitation of hepatitis B virus (HBV) DNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system.

Hochberger S, Althof D, Gallegos de Schrott R, Nachbaur N, Röck H, Leying H.

J Clin Virol. 2006 Apr;35(4):373-80. Epub 2006 Feb 7.

PMID:
16461000
3.

Biotin in vitro translation, nonradioactive detection of cell-free synthesized proteins.

Hoeltke HJ, Ettl I, Strobel E, Leying H, Zimmermann M, Zimmermann R.

Biotechniques. 1995 May;18(5):900-4, 906-7.

PMID:
7619497
4.

Expression of capsular polysaccharide determines serum resistance in Escherichia coli K92.

Suerbaum S, Friedrich S, Leying H, Opferkuch W.

Zentralbl Bakteriol. 1994 Aug;281(2):146-57.

PMID:
7858342
5.

Ultrastructure and biochemical studies of the flagellar sheath of Helicobacter pylori.

Geis G, Suerbaum S, Forsthoff B, Leying H, Opferkuch W.

J Med Microbiol. 1993 May;38(5):371-7.

PMID:
8487294
6.

Cloning and genetic characterization of a Helicobacter pylori flagellin gene.

Leying H, Suerbaum S, Geis G, Haas R.

Mol Microbiol. 1992 Oct;6(19):2863-74.

PMID:
1435261
7.

Lipopolysaccharide alterations responsible for combined quinolone and beta-lactam resistance in Pseudomonas aeruginosa.

Leying HJ, Büscher KH, Cullmann W, Then RL.

Chemotherapy. 1992;38(2):82-91.

PMID:
1591950
8.

Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori.

Suerbaum S, Leying H, Klemm K, Opferkuch W.

Eur J Clin Microbiol Infect Dis. 1991 Feb;10(2):92-3. No abstract available.

PMID:
1864281
9.

Carbapenem resistance in Enterobacter aerogenes is due to lipopolysaccharide alterations.

Leying H, Cullmann W, Dick W.

Chemotherapy. 1991;37(2):106-13.

PMID:
2032467
10.

Imipenem resistance in Acinetobacter baumanii is due to altered penicillin-binding proteins.

Gehrlein M, Leying H, Cullmann W, Wendt S, Opferkuch W.

Chemotherapy. 1991;37(6):405-12.

PMID:
1760939
11.

Unusual fatty acid substitution in lipids and lipopolysaccharides of Helicobacter pylori.

Geis G, Leying H, Suerbaum S, Opferkuch W.

J Clin Microbiol. 1990 May;28(5):930-2.

12.

Influence of beta-lactam antibiotics on serum resistance of K1-positive blood culture isolates of Escherichia coli.

Suerbaum S, Leying H, Meyer B, Opferkuch W.

Antimicrob Agents Chemother. 1990 Apr;34(4):628-31.

13.
14.

Role of the outer membrane for quinolone resistance in enterobacteria.

Dechène M, Leying H, Cullmann W.

Chemotherapy. 1990;36(1):13-23.

PMID:
2106416
15.

Ultrastructure and chemical analysis of Campylobacter pylori flagella.

Geis G, Leying H, Suerbaum S, Mai U, Opferkuch W.

J Clin Microbiol. 1989 Mar;27(3):436-41.

16.

Interaction of Escherichia coli and macrophages: alteration by treatment of bacteria with beta-lactam antibiotics.

Opferkuch W, Büscher KH, Leying H, Klimetzek V.

Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Aug;266(1-2):116-26.

PMID:
3321761
17.

Influence of beta-lactam antibiotics and ciprofloxacin on cell envelope of Escherichia coli.

Suerbaum S, Leying H, Kroll HP, Gmeiner J, Opferkuch W.

Antimicrob Agents Chemother. 1987 Jul;31(7):1106-10.

18.

Influence of beta-lactam antibiotics and ciprofloxacin on composition and immunogenicity of Escherichia coli outer membrane.

Leying H, Suerbaum S, Kroll HP, Karch H, Opferkuch W.

Antimicrob Agents Chemother. 1986 Sep;30(3):475-80.

19.

Three-dimensional structure of fimbriae determines specificity of immune response.

Karch H, Leying H, Goroncy-Bermes P, Kroll HP, Opferkuch W.

Infect Immun. 1985 Nov;50(2):517-22.

20.

Supplemental Content

Loading ...
Support Center